The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex several-stage synthetic process. Preliminary routes focused on amino acid chain section coupling, utilizing https://owainrcdt838382.aioblogs.com/93418214/creation-and-research-uses-of-retatrutide